SCHEMBL30316980

SCHEMBL30316980

Fc1n[nH]c2nccnc12

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.35
▸ GRM4 Q14833 5/20 0.32
▸ MAPK14 Q16539 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6358084 0.75 MAPK1 (0.38) MAPK1GRM4
SCHEMBL19801401 0.73 GRM4 (0.33) MAPK1GRM4
SCHEMBL30876173 0.71 MAPK1 (0.35) MAPK1
SCHEMBL3950985 0.71 PDPK1 (0.38) MAPK1GRM4
SCHEMBL30180924 0.71 DYRK1A (0.38) MAPK1
SCHEMBL14763598 0.71 DYRK1A (0.38) MAPK1
SCHEMBL14906033 0.71 MAPK1 (0.45) MAPK1
SCHEMBL30398918 0.71 GRM4 (0.37) MAPK1GRM4
SCHEMBL30316949 0.69 GRM4 (0.31) GRM4
SCHEMBL19258970 0.68 YTHDC1 (0.40) MAPK1GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4363423-A1 CDK2 INHIBITORS Blueprint Medicines Corporation (US) 2024-05-08 — — EP disclosed
WO-2023278326-A1 CDK2 INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2023-01-05 — — WO disclosed
Send feedback